We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
TestAmerica Addresses the Testing Challenges of Emerging Contaminants
News

TestAmerica Addresses the Testing Challenges of Emerging Contaminants

TestAmerica Addresses the Testing Challenges of Emerging Contaminants
News

TestAmerica Addresses the Testing Challenges of Emerging Contaminants

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "TestAmerica Addresses the Testing Challenges of Emerging Contaminants"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The presentation will be given on March 28, 2012 in La Jolla, California.

The technical session DoD Emerging Contaminants covers the revolutionary method developments for detecting and quantifying new contaminants of concern. Dr. Weir will highlight the latest challenges and limitations of traditional analytical methods for atypical matrices. A comprehensive review of analytical techniques required to produce significant data, in addition to the issues regarding detection limits based upon the availability of commercial standards and instrumentation, will also be discussed.

Dr. Weir has over 20 years of experience in the environmental testing industry. He completed his postdoctoral work at the National Research Council of Canada and the Department of Energy’s Radiation Laboratory at Notre Dame, before entering into the commercial environmental industry. In subsequent years, Dr. Weir has worked in laboratories across Canada and the United States, specializing in non-routine analytical testing. His work has primarily focused on emerging contaminant analysis, including pharmaceuticals, hormones, and brominated diphenyl ethers. As TestAmerica West Sacramento’s Quality Control Officer, Dr. Weir’s contributions continue to lead in the development of rigorous testing protocols for new contaminant analyses to assure accurate and defensible results.

Advertisement